Lyme Disease

Infectious Diseases of the Fetus and Newborn Infant

Volumn , Issue , 2006, Pages 485-497

  Shapiro, Eugene D ^a,b   Gerber, Michael A ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Children's Hospital   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750423570     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160537-0/50017-7     Document Type: Chapter

References (113)

1. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arth Rheum 1977, 20:7-17.
2. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease: a tick-borne spirochetosis?. Science 1982, 216:1317-1319.
3. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983, 308:733-740.
4. Steere AC Lyme disease. N Engl J Med 2001, 345:115-125.
5. Ingall D, Dobson SRM, Musher D Syphilis. Infectious Diseases of the Fetus and Newborn Infant 1990, 367-394. WB Saunders, Philadelphia. 3rd ed. J.S. Remington, J.D. Klein (Eds.).
6. Fuchs PC, Oyama AA Neonatal relapsing fever due to transplacental transmission of Borrelia. JAMA 1969, 208:690-692.
7. Coghlan JD, Bain AD Leptospirosis in human pregnancy followed by death of the foetus. BMJ 1969, 1:228-230.
8. Lindsay S, Luke IW Fatal leptospirosis (Weil's disease) in a newborn infant. J Pediatr 1949, 34:90-94.
9. Steenbarger JR Congenital tick-borne relapsing fever: report of a case with first documentation of transplacental transmission. Birth Defects 1982, 18:39-45.
10. Yagupsky P, Moses S Neonatal Borrelia species infection (relapsing fever). Am J Dis Child 1985, 139:74-76.
11. Lane RS, Burgdorfer W, Hayes SF, Barbour AG Isolation of a spirochete from the soft tick, Ornithodoros coriaceus: a possible agent of epizootic bovine abortion. Science 1985, 230:85-87.
12. Lane RS, Piesman J, Burgdorfer W Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol 1991, 36:587-609.
13. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001, 345:79-84.
14. Piesman J, Mather TN, Sinsky R Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 1987, 25:557-558.
15. Piesman J, Maupin GO, Campos EG, et al. Duration of adult female Ixodes dammini attachment and transmission of Borrelia burgdorferi, description of a needle aspiration isolation method. J Infect Dis 1991, 163:895-897.
16. Piesman J Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis 1993, 167:1082-1085.
17. Falco RC, Fish D, Piesman J Duration of tick bites in a Lyme disease-endemic area. Am J Epidemiol 1996, 143:187-192.
18. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med 1992, 327:1769-1773.
19. Shapiro ED Doxycycline for tick bites-not for everyone. N Engl J Med 2001, 345:133-134.
20. Schwartz B, Nadelman RB, Fish D, et al. Entomologic and demographic correlates of anti-tick saliva antibody in a prospective study of tick bite subjects in Westchester County, New York. Am J Trop Med Hyg 1993, 48:50-57.
21. Lyme disease: United States, 2000. MMWR Morb Mortal Wkly Rep 2002, 51:29-31. CDC.
22. Hanrahan JP, Benach JL, Coleman JL, et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 1984, 150:489-496.
23. Steere AC, Taylor E, Wilson ML, et al. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis 1986, 154:94-300.
24. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586.
25. Bergstrom S, Noppa L, Gylfe A, Ostberg Y Molecular and cellular biology of Borrelia burgdorferi sensu lato. Lyme Borreliosis: Biology, Epidemiology and Control 2002, 47-90. CABI Publishing, Wallingford, UK. J.S. Gray, O. Kahl, R.S. Lane, G. Stanek (Eds.).
26. Nadelman RB, Wormser GP Lyme borreliosis. Lancet 1998, 352:557-565.
27. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270-1274.
28. Coleman JL, Gebbia JA, Piesman J, et al. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997, 89:1111-1119.
29. Coburn J, Leong JM, Erban JK Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A 1993, 90:7059-7063.
30. Coburn J, Magoun L, Bodary, Leong KM Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of Lyme disease spirochetes to human cells. Infect Immun 1998, 66:1946-1952.
31. Guo BP, Brown EL, Dorward DW Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 1998, 30:711-723.
32. Probert WS, Johnson BJ Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 1998, 30:1003-1015.
33. Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999, 67:3518-3524.
34. Weiss JJ, McCracken BA, Ma Y, et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol 1999, 162:948-956.
35. Barthold SW, de Souza M Exacerbation of Lyme arthritis in beige mice. J Infect Dis 1995, 172:778-784.
36. Mullegger RR, McHugh G, Ruthazer R, et al. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol 2000, 115:1115-1123.
37. Krause A, Brade V, Schoerner C, et al. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation. Arthritis Rheum 1991, 34:393-402.
38. Akin E, McHugh GL, Flavell RA, et al. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 1999, 67:173-181.
39. Roberts ED, Bohm RP, Lowrie RC, et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722-732.
40. Cadavid D, O'Neill T, Schaefer H, Pachner AR Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest 2000, 80:1043-1054.
41. H1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain. J Infect Dis 1998, 177:242-246.
42. Barthold SW, Feng S, Bockenstedt LK, et al. Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis 1997, 25(Suppl 1):S9-S17.
43. Steere AC, Duray PH, Butcher EC Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum 1988, 31:487-495.
44. Vincent MS, Roessner K, Sellati T, et al. Lyme arthritis synovial gamma delta T cells respond to Borrelia burgdorferi lipoproteins and lipidated hexapeptides. J Immunol 1998, 161:5762-5771.
45. Chen J, Field JA, Glickstein L, et al. Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 1999, 42:1813-1822.
46. Gross DM, Steere AC, Huber BT T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998, 160:1022-1028.
47. Yin Z, Braun J, Neure L, et al. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997, 40:69-79.
48. Dressler F, Whalen JA, Reinhardt BN, Steere AC Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993, 167:392-400.
49. Barthold SW, Beck DS, Hansen GM, et al. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990, 162:133-138.
50. Steere AC, Baxter-Lowe LA Association of chronic, treatment-resistant Lyme arthritis with rheumatoid arthritis (RA) alleles. Arthritis Rheum 1998, 41(Suppl):S81.
51. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994, 37:878-888.
52. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703-706.
53. Anderson JF, Johnson RC, Margnarelli LA Seasonal prevalence of Borrelia burgdorferi in natural populations of white-footed mice, Peromyscus leucopus. J Clin Microbiol 1987, 25:1564-1566.
54. Burgess EC, Windberg LA Borrelia sp. infection in coyotes, black-tailed jack rabbits and desert cottontails in southern Texas. J Wildl Dis 1989, 25:47-51.
55. Burgess EC Borrelia burgdorferi infection in Wisconsin horses and cows. Ann N Y Acad Sci 1988, 539:235-243.
56. Burgess EC, Wachal MD, Cleven TD Borrelia burgdorferi infection in dairy cows, rodents, and birds from four Wisconsin dairy farms. Vet Microbiol 1993, 35:61-77.
57. Gustafson JM, Burgess EC, Wachal MD, Steinberg H Intrauterine transmission of Borrelia burgdorferi in dogs. Am J Vet Res 1993, 54:882-890.
58. Burgess EC, Gendron-Fitzpatrick A, Mattison M Foal mortality associated with natural infection of pregnant mares with Borrelia burgdorferi. Proceedings of the 5th International Conference on Equine Infectious Diseases 1989, 217-220. University Press of Kentucky, Lexington, Ky. D.G. Powell (Ed.).
59. Silver RM, Yang L, Daynes RA, et al. Fetal outcome in murine Lyme disease. Infect Immun 1995, 63:66-72.
60. Moody KD, Barthold SW Relative infectivity of Borrelia burgdorferi in Lewis rats by various routes of inoculation. Am J Trop Med Hyg 1991, 44:135-139.
61. Woodrum JE, Oliver JH Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters. J Parasitol 1999, 85:426-430.
62. Mather TN, Telford SR, Adler GH Absence of transplacental transmission of Lyme disease spirochetes from reservoir mice ( Peromyscus leucopus) to their offspring. J Infect Dis 1991, 164:564-567.
63. Schlesinger PA, Duray PH, Burke BA, et al. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985, 103:67-68.
64. Oppenheimer EH, Hardy JB Congenital syphilis in the newborn infant: clinical and pathological observations in recent cases. Johns Hopkins Med J 1971, 129:63-82.
65. MacDonald AB, Benach JL, Burgdorfer W Stillbirth following maternal Lyme disease. N Y State J Med 1987, 87:615-616.
66. Weber K, Bratzke HJ, Neubert U, et al. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988, 7:286-289.
67. Trevisan G, Stinco G, Cinco M Neonatal skin lesions due to a spirochetal infection: a case of congenital Lyme borreliosis?. Int J Dermatol 1997, 36:677-680.
68. Grandsaerd MJ Lyme borreliosis as a cause of facial palsy during pregnancy. Eur J Obstet Gynecol Reprod Biol 2000, 91:99-101.
69. Mikkelson AL, Palle C Lyme disease during pregnancy. Acta Obstet Gynecol Scand 1987, 6:477-478.
70. Schaumann R Facial palsy caused by Borrelia infection in a twin pregnancy in an area of nonendemicity. Clin Infect Dis 1999, 29:955-956.
71. Schutzer SE, Janniger CK, Schwartz RA Lyme disease during pregnancy. Cutis 1991, 47:267-268.
72. Stiernstedt G Lyme borreliosis during pregnancy. Scand J Infect Dis 1990, 71(Suppl):99-100.
73. Figueroa R, Bracero LA, Aguero-Rosenfeld M, et al. Confirmation of Borrelia burgdorferi spirochetes by polymerase chain reaction in placentas of women with reactive serology for Lyme antibodies. Gynecol Obstet Invest 1996, 41:240-243.
74. Markowitz LE, Steere AC, Benach JL, et al. Lyme disease during pregnancy. JAMA 1986, 255:3394-3396.
75. Ciesielski CA, Russell H, Johnson S, et al. Prospective study of pregnancy outcome in women with Lyme disease. Twenty-seventh International Conference of Antimicrobial Agents and Chemotherapy, New York, 1987. Abstract 39.
76. Maraspin V, Cimperman J, Lotric-Furlan S, et al. Erythema migrans in pregnancy. Wien Klin Wochenschr 1999, 111:933-940.
77. Williams CL, Benach JL, Curran AS, et al. Lyme disease during pregnancy: a cord blood serosurvey. Ann N Y Acad Sci 1988, 539:504-506.
78. Nadal D, Hunziker UA, Bucher HU, et al. Infants born to mothers with antibodies against Borrelia burgdorferi at delivery. Eur J Pediatr 1989, 148:426-427.
79. Gerber MA, Zalneraitis EL Childhood neurologic disorders and Lyme disease during pregnancy. Pediatr Neurol 1994, 11:41-43.
80. Strobino B, Abid S, Gewitz M Maternal Lyme disease and congenital heart disease: a case-control study in an endemic area. Am J Obstet Gynecol 1999, 180:711-716.
81. Strobino BA, Williams CL, Abid S, et al. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol 1993, 169:367-374.
82. Williams CL, Strobino B, Weinstein A, et al. Maternal Lyme disease and congenital malformations: a cord blood serosurvey in endemic and control areas. Paediatr Perinat Epidemiol 1995, 9:320-330.
83. Lischer CJ, Leutenegger CM, Lutz BH Diagnosis of Lyme disease in two cows by the detection of Borrelia burgdorferi DNA. Vet Rec 2000, 146:497-499.
84. Schmidt BL, Aberer E, Stockenhiber C, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme borreliosis. Diagn Microbiol Infect Dis 1995, 21:121-128.
85. Shapiro ED, Gerber MA Lyme disease. Clin Infect Dis 2000, 31:533-542.
86. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med 1998, 339:209-216.
87. MMWR Morb Mortal Wkly Rep 1990, 39(RR-13):1-43. Case definitions for public health surveillance.
88. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995, 44:590-591. Centers for Disease Control and Prevention.
89. Food and Drug Administration. FDA Public Health Advisory: Assays for Antibodies to Borrelia burgdorferi: Limitations, Use, and Interpretation for Supporting a Clinical Diagnosis of Lyme Disease. July 7, 1997.
90. Wormser GP, Forseter G, Cooper D, et al. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans. JAMA 1992, 268:1311-1313.
91. Hyde FW, Johnson RC, White TJ, et al. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 1989, 27:58-61.
92. Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis 2003, 3:489-500.
93. Klempner MS, Schmid CH, Hu L, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 2001, 110:217-219.
94. Bunikis J, Barbour AG Laboratory testing for suspected Lyme disease. Med Clin North Am 2002, 86:311-340.
95. Craft JE, Grodzicki RL, Steere AC Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis 1984, 149:789-795.
96. Hilton E, Tramontano A, DeVoti J, Sood SK Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 1997, 35:774-776.
97. Feder HM, Gerber MA, Luger SW, Ryan RW Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis 1992, 15:788-793.
98. Kalish RA, Kaplan RF, Taylor E, et al. Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis 2001, 183:453-460.
99. Evaluation of serologic tests for Lyme disease: report of a national evaluation. Lyme Dis Surveill Summ 1991, 1:1-8. Bacterial Zoonoses Branch, Centers for Disease Control and Prevention.
100. Bakken LL, Callister SM, Wand PJ, Schell RF Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program. J Clin Microbiol 1997, 35:537-543.
101. Schwartz BS, Goldstein MD, Ribeiro JMC, et al. Antibody testing in Lyme disease. A comparison of results in four laboratories. JAMA 1989, 262:3431-3434.
102. Bakken LL, Case KL, Callister SM, et al. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992, 268:891-895.
103. Luger SW, Krauss E Serologic tests for Lyme disease. Interlaboratory variability. Arch Intern Med 1990, 150:761-776.
104. Seltzer EG, Shapiro ED Misdiagnosis of Lyme disease: when not to order serologic tests. Pediatr Infect Dis J 1996, 15:762-763.
105. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997, 127:1109-1123.
106. Nichol G, Dennis DT, Steere AC, et al. Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Intern Med 1998, 128:37-48.
107. Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis 1990, 161:1203-1209.
108. Bracero LA, Wormser GP, Leikin E, Tejani N Prevalence of seropositivity to the Lyme disease spirochete during pregnancy in an epidemic area. A preliminary report. J Matern Fetal Invest 1992, 2:265-268.
109. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 2000, 31(Suppl 1):S1-S14.
110. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003, 138:697-704.
111. Elliott DJ, Eppes SC, Klein JD Teratogen update: Lyme disease. Teratology 2001, 64:276-281.
112. Shapiro ED Long-term outcomes of persons with Lyme disease. Vector Borne Zoonotic Dis 2002, 2:279-281.
113. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001, 345:85-92.